Management of Pregnancy and Contraception in Congenital Heart Disease

Congenital Heart Disease in Adults

Volumn , Issue , 2008, Pages 194-220

  Child, John S ^a   Perloff, Joseph K ^a   Koos, Brian ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85159493834     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5894-6.50013-7     Document Type: Chapter

References (129)

1. U Thilen and SB Olsson (1997) Pregnancy and heart disease: a review. Eur J Obstet Gynecol Reprod Biol 75 43-50.
2. SA Thorne (2004) Pregnancy in heart disease. Heart 90 450-456.
3. PJ Steer, MA Gatzoulis and P Baker (Eds) (2006) Heart Disease and Pregnancy London: RCOG Press
4. A Vahanian, H Baumgartner, J Bax, et al. (2007) Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 230-268.
5. RO Bonow, BA Carabello, K Chatterjee, et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48 e1-e148.
6. RO Bonow, BA Carabello, C Kanu, et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 e84-e231.
7. JK Perloff and JS Child (Eds) (1998) Congenital Heart Disease in Adults 2nd ed. Philadelphia: W.B. Saunders
8. CA Warnes (2003) Pregnancy and contraception. MA Gatzoulis, GD Webb, PEF Daubeney,(Eds) Diagnosis and Management of Adult Congenital Heart Disease Edinburgh: Churchill Livingstone 135-144.
9. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24 761-781.
10. BJ Koos (2004) Management of uncorrected, palliated, and repaired cyanotic congenital heart disease in pregnancy. Prog Pediatr Cardiol 19 25-45.
11. JK Perloff and B Koos (1998) Pregnancy and congenital heart disease: the mother and the fetus. JK Perloff, JS Child,(Eds) Congenital Heart Disease in Adults 2nd ed. Philadelphia: W.B. Saunders 144-164.
12. CA Warnes, R Liberthson, GK Danielson, et al. (2001) Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 37 1170-1175.
13. RG Williams, GD Pearson, RJ Barst, et al. (2006) Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol 47 701-707.
14. CA Warnes (2005) The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 46 1-8.
15. AC van Oppen, RH Stigter and HW Bruinse (1996) Cardiac output in normal pregnancy: a critical review. Obstet Gynecol 87 310-318.
16. U Elkayam (2005) Pregnancy and cardiovascular disease. DP Zipes, P Libby, RO Bonow, E Braunwald,(Eds) Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 7th ed. Philadelphia: Elsevier Saunders 1965-1984.
17. T Geva, MB Mauer, L Striker, et al. (1997) Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133 53-59.
18. NA Kametas, F McAuliffe, E Krampl, et al. (2003) Maternal cardiac function in twin pregnancy. Obstet Gynecol 102 806-815.
19. P Manalo-Estrella and AE Barker (1967) Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol 83 336-341.
20. FJ Cavanzo and HB Taylor (1969) Effect of pregnancy on the human aorta and its relationship to dissecting aneurysms. Am J Obstet Gynecol 105 567-568.
21. FF Immer, AG Bansi, AS Immer-Bansi, et al. (2003) Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 76 309-314.
22. GD Bryant-Greenwood and C Schwabe (1994) Human relaxins: chemistry and biology. Endocr Rev 15 5-26.
23. MD McColl, JE Ramsay, RC Tait, et al. (1997) Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 78 1183-1188.
24. E Grandone, M Margaglione, D Colaizzo, et al. (1998) Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 179 1324-1328.
25. A Gerhardt, RE Scharf, MW Beckmann, et al. (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 342 374-380.
26. CJ Lockwood (1999) Heritable coagulopathies in pregnancy. Obstet Gynecol Surv 54 754-765.
27. MC Walker, PR Garner, EJ Keely, et al. (1997) Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 177 162-169.
28. E Gelson, M Johnson, M Gatzoulis and A Uebing (2007) Cardiac disease in pregnancy. Part 1: congenital heart disease. Obstetr Gynaecol 9 15-20.
29. CE Head and SA Thorne (2005) Congenital heart disease in pregnancy. Postgrad Med J 81 292-298.
30. SC Siu and JM Colman (2001) Heart disease and pregnancy. Heart 85 710-715.
31. S Thorne, A MacGregor and C Nelson-Piercy (2006) Risks of contraception and pregnancy in heart disease. Heart 92 1520-1525.
32. W Wilson, KA Taubert, M Gewitz, et al. (2007) Prevention of infective endocarditis. Guidelines from the American Heart Association. A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 1736-1754.
33. U Elkayam and F Bitar (2005) Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol 46 223-230.
34. JI Hoffman, S Kaplan and RR Liberthson (2004) Prevalence of congenital heart disease. Am Heart J 147 425-439.
35. JI Hoffman and S Kaplan (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39 1890-1900.
36. J Burn, P Brennan, J Little, et al. (1998) Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351 311-316.
37. G Calcagni, MC Digilio, A Sarkozy, et al. (2007) Familial recurrence of congenital heart disease: an overview and review of the literature. Eur J Pediatr 166 111-116.
38. ME Pierpont, CT Basson and DW Benson Jr (2007) et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115 3015-3038.
39. JM Meijer, PG Pieper, W Drenthen, et al. (2005) Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 91 801-805.
40. LM Beauchesne, CA Warnes, HM Connolly, et al. (2005) Prevalence and clinical manifestations of 22q11. 2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 45 595-598.
41. IS Park, JK Ko, YH Kim, et al. (2007) Cardiovascular anomalies in patients with chromosome 22q11. 2 deletion: a Korean multicenter study. Int J Cardiol 114 230-235.
42. E Cohen, EW Chow, R Weksberg and AS Bassett (1999) Phenotype of adults with the 22q11 deletion syndrome: a review. Am J Med Genet 86 359-365.
43. DA Driscoll (2001) Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med 3 14-18.
44. DM McDonald-McGinn, MK Tonnesen, A Laufer-Cahana, et al. (2001) Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!. Genet Med 3 23-29.
45. SC Siu, M Sermer, JM Colman, et al. (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104 515-521.
46. SC Siu, M Sermer, DA Harrison, et al. (1997) Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 96 2789-2794.
47. P Khairy, DW Ouyang, SM Fernandes, et al. (2006) Pregnancy outcomes in women with congenital heart disease. Circulation 113 517-524.
48. SC Siu, JM Colman, S Sorensen, et al. (2002) Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105 2179-2184.
49. W Drenthen, PG Pieper, JW Roos-Hesselink, et al. (2007) Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 49 2303-2311.
50. U Elkayam, MW Akhter, H Singh, et al. (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 2050-2055.
51. U Elkayam and F Bitar (2005) Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol 46 403-410.
52. U Elkayam, PP Tummala, K Rao, et al. (2001) Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 1567-1571.
53. A Hameed, IS Karaalp, PP Tummala, et al. (2001) The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 37 893-899.
54. SC Reimold and JD Rutherford (2003) Clinical practice. Valvular heart disease in pregnancy. N Engl J Med 349 52-59.
55. CK Silversides, JM Colman, M Sermer and SC Siu (2003) Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 91 1382-1385.
56. KK Stout and CM Otto (2007) Pregnancy in women with valvular heart disease. Heart 93 552-558.
57. CA Warnes (2004) Pregnancy and pulmonary hypertension. Int J Cardiol 97(1 Suppl), 11-13.
58. J Shime, EJ Mocarski, D Hastings, et al. (1987) Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol 156 313-322.
59. M Zuber, N Gautschi, E Oechslin, et al. (1999) Outcome of pregnancy in women with congenital shunt lesions. Heart 81 271-275.
60. R Chugh (2004) Management of pregnancy in patients with congenital heart disease and systemic ventricular failure. Prog Pediatr Cardiol 19 47-60.
61. MA Mendelson (2004) Pregnancy in patients with obstructive lesions: aortic stenosis, coarctation of the aorta and mitral stenosis. Prog Pediatr Cardiol 19 61-70.
62. LJ Meijboom, W Drenthen, PG Pieper, et al. (2006) Obstetric complications in Marfan syndrome. Int J Cardiol 110 53-59.
63. LJ Meijboom, FE Vos, J Timmermans, et al. (2005) Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 26 914-920.
64. WO Cooper, S Hernandez-Diaz, PG Arbogast, et al. (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 2443-2451.
65. JM Friedman (2006) ACE inhibitors and congenital anomalies. N Engl J Med 354 2498-2500.
66. BM Weiss, LK von Segesser, E Alon, et al. (1998) Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 179 1643-1653.
67. W Drenthen, PG Pieper, JW Roos-Hesselink, et al. (2006) Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart 92 1838-1843.
68. JW Vriend, W Drenthen, PG Pieper, et al. (2005) Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 26 2173-2178.
69. LM Beauchesne, HM Connolly, NM Ammash and CA Warnes (2001) Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 38 1728-1733.
70. MD Plunkett, LM Bond and DM Geiss (2000) Staged repair of acute type I aortic dissection and coarctation in pregnancy. Ann Thorac Surg 69 1945-1947.
71. CK Silversides, JM Colman, M Sermer, et al. (2003) Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol 91 1386-1389.
72. JS Child (2004) Fallot's tetralogy and pregnancy: prognostication and prophesy. J Am Coll Cardiol 44 181-183.
73. GR Veldtman, HM Connolly, M Grogan, et al. (2004) Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 44 174-180.
74. U Neumayer and J Somerville (1997) Outcome of pregnancies in patients with complex pulmonary atresia. Heart 78 16-21.
75. N Jayaprasad, F Johnson and K Venugopal (2006) Congenital complete heart block and maternal connective tissue disease. Int J Cardiol 112 153-158.
76. BM Weiss and OM Hess (2000) Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 21 104-115.
77. SM Yentis, PJ Steer and F Plaat (1998) Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 105 921-922.
78. EM Chau, KY Fan and WH Chow (2007) Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol 120 301-305.
79. J Aboulhosn and JS Child (2007) The adult with a Fontan operation. Curr Cardiol Rep 9 331-335.
80. RN Gates, H Laks, DC Drinkwater Jr., et al. (1997) The Fontan procedure in adults. Ann Thorac Surg 63 1085-1090.
81. G Barber, T Di Sessa, JS Child, et al. (1988) Hemodynamic responses to isolated increments in heart rate by atrial pacing after a Fontan procedure. Am Heart J 115 837-841.
82. MG Earing, F Cetta, DJ Driscoll, et al. (2005) Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol 96 291-298.
83. F Walker (2007) Pregnancy and the various forms of the Fontan circulation. Heart 93 152-154.
84. W Drenthen, PG Pieper, JW Roos-Hesselink, et al. (2006) Pregnancy and delivery in women after Fontan palliation. Heart 92 1290-1294.
85. MM Canobbio, DD Mair, M van der Velde and BJ Koos (1996) Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 28 763-767.
86. MM Canobbio, CD Morris, TP Graham and MJ Landzberg (2006) Pregnancy outcomes after atrial repair for transposition of the great arteries. Am J Cardiol 98 668-672.
87. W Drenthen, PG Pieper, M Ploeg, et al. (2005) Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 26 2588-2595.
88. A Guedes, LA Mercier, L Leduc, et al. (2004) Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 44 433-437.
89. M Genoni, R Jenni, SP Hoerstrup, et al. (1999) Pregnancy after atrial repair for transposition of the great arteries. Heart 81 276-277.
90. HM Connolly, M Grogan and CA Warnes (1999) Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 33 1692-1695.
91. HC Dietz and RE Pyeritz (1995) Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet (4 Spec No), 1799-1809.
92. JC Dean (2002) Management of Marfan syndrome. Heart 88 97-103.
93. AH Child (1997) Marfan syndrome—current medical and genetic knowledge: how to treat and when. J Card Surg 12(2 Suppl), 131-135. discussion 135–136
94. EH Aburawi and J O'Sullivan (2007) Relation of aortic root dilatation and age in Marfan's syndrome. Eur Heart J 28 376-379.
95. VL Gott, PS Greene, DE Alejo, et al. (1999) Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med 340 1307-1313.
96. T Treasure (2000) Cardiovascular surgery for Marfan syndrome. Heart 84 674-678.
97. M Groenink, TA Lohuis, JG Tijssen, et al. (1999) Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart 82 499-504.
98. AM Lazarevic, S Nakatani, Y Okita, et al. (2006) Determinants of rapid progression of aortic root dilatation and complications in Marfan syndrome. Int J Cardiol 106 177-182.
99. SM Bates, IA Greer, J Hirsh and JS Ginsberg (2004) Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl), 627S-644S.
100. WS Chan, S Anand and JS Ginsberg (2000) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160 191-196.
101. C Choi, S Midwall, P Chaille and CR Conti (2007) Treatment of mechanical valve thrombosis during pregnancy. Clin Cardiol 30 271-276.
102. LS De Santo, G Romano, A Della Corte, et al. (2005) Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg 130 13-19.
103. JS Ginsberg, WS Chan, SM Bates and S Kaatz (2003) Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 163 694-698.
104. JS Ginsberg, J Hirsh, DC Turner, et al. (1989) Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 61 197-203.
105. N Vitale, M De Feo, LS De Santo, et al. (1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33 1637-1641.
106. M Cotrufo, M De Feo, LS De Santo, et al. (2002) Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 99 35-40.
107. N Seshadri, SZ Goldhaber, U Elkayam, et al. (2005) The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J 150 27-34.
108. MA Borger, J Ivanov, S Armstrong, et al. (2006) Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 15 49-55. discussion 55–46
109. A Dore and J Somerville (1997) Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 18 1659-1662.
110. NG Smedira, EH Blackstone, EE Roselli, et al. (2006) Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explanation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg 131 558-564. e4
111. GB Luciani, A Favaro, G Casali, et al. (2005) Reoperations for aortic aneurysm after the Ross procedure. J Heart Valve Dis 14 766-772. discussion 772–773
112. WS Avila, EG Rossi, M Grinberg and JA Ramires (2002) Influence of pregnancy after bioprosthetic valve replacement in young women: a prospective five-year study. J Heart Valve Dis 11 864-869.
113. WR Jamieson, DC Miller, CW Akins, et al. (1995) Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 60(2 Suppl), S282-286. discussion S287
114. E Salazar, N Espinola, L Roman and JM Casanova (1999) Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J 137 714-720.
115. Z Al-Halees, F Pieters, F Qadoura, et al. (2002) The Ross procedure is the procedure of choice for congenital aortic valve disease. J Thorac Cardiovasc Surg 123 437-441. discussion 441–432
116. E Salazar, R Izaguirre, J Verdejo and O Mutchinick (1996) Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 27 1698-1703.
117. J Hirsh, V Fuster, J Ansell and JL Halperin (2003) American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41 1633-1652.
118. J Wesseling, D Driel, HS Van Heymans, et al. (2001) Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost 85 609-613.
119. J Ansell, J Hirsh, L Poller, H Bussey, et al. (2004) The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl), 204S-233S.
120. PV Hauschka, JB Lian, DE Cole and CM Gundberg (1989) Osteocalcin and matrix Gla protein: vitamin K–dependent proteins in bone. Physiol Rev 69 990-1047.
121. C Maillard, M Berruyer, CM Serre, et al. (1992) Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 130 1599-1604.
122. PA Price (1988) Role of vitamin-K-dependent proteins in bone metabolism. Annu Rev Nutr 8 565-583.
123. JG Hall, RM Pauli and KM Wilson (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68 122-140.
124. JM Pettifor and R Benson (1975) Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86 459-462.
125. JS Ginsberg, I Greer and J Hirsh (2001) Use of antithrombotic agents during pregnancy. Chest 119(1 Suppl), 122S-131S.
126. J Hirsh, M O'Donnell and JW Eikelboom (2007) Beyond unfractionated heparin and warfarin: current and future advances. Circulation 116 552-560.
127. J Hirsh and R Raschke (2004) Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl), 188S-203S.
128. Lovenox Highlights of prescribing information. Available at: http://products.sanofi-aventis.us/lovenox/lovenox.html. October 2007 ed. Sanofi-Aventis U.S.; 2007
129. PD Miner (2004) Contraceptive choices for females with congenital heart disease. Prog Pediatr Cardiol 19 15-24.